A carregar...

High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study

While breast cancer prognoses are generally good, different molecular subtypes are known to have varying outcomes. Previous studies using breast cancer registries have suggested that high parity may be an adverse prognostic factor in luminal breast cancer, but breast cancer subtype definitions have...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Jääskeläinen, Anniina, Roininen, Nelli, Karihtala, Peeter, Jukkola, Arja
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7457016/
https://ncbi.nlm.nih.gov/pubmed/32923400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01470
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!